glp-1 news today october 2025 health pharma obesity drugs Outlook for obesity in 2025: more GLP-1 RA prescription trends: January
Description
Losing the Weight Loss Meds" by Drs
Discover how GLP-1 medications like Wegovy and Zepbound reduce triglycerides, LDL cholesterol, and cardiovascular risk through proven metabolic effects beyond weight loss alone.
Supports Metabolic Wellness Helps support gut-related metabolic pathways
International distributors targeting the metabolic health trend
Some commonly used GLP-1 receptor agonists include exenatide, liraglutide, and dulaglutide
